Effectiveness and safety of direct-acting antiviral therapies in chronic hepatitis C infections patients with cirrhosis in Turkey
dc.contributor.author | Tabak, F. | |
dc.contributor.author | Çuvalcı, Nefise Ö. | |
dc.contributor.author | Kurtaran, B. | |
dc.contributor.author | Önlen, Yusuf | |
dc.contributor.author | Sarı, Nagehan Didem | |
dc.contributor.author | Kaya, Şükrü | |
dc.contributor.author | Yamazhan, Tansu | |
dc.date.accessioned | 2020-05-01T09:11:50Z | |
dc.date.available | 2020-05-01T09:11:50Z | |
dc.date.issued | 2018 | |
dc.department | DÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü | en_US |
dc.description | International Liver Congress (ILC) -- APR 11-15, 2018 -- Paris, FRANCE | en_US |
dc.description | WOS: 000461068601206 | en_US |
dc.description.abstract | … | en_US |
dc.description.sponsorship | European Assoc Study Liver | en_US |
dc.identifier.doi | 10.1016/S0168-8278(18)30814-6 | en_US |
dc.identifier.endpage | S298 | en_US |
dc.identifier.issn | 0168-8278 | |
dc.identifier.issn | 1600-0641 | |
dc.identifier.startpage | S297 | en_US |
dc.identifier.uri | https://doi.org/10.1016/S0168-8278(18)30814-6 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12684/5784 | |
dc.identifier.volume | 68 | en_US |
dc.identifier.wos | WOS:000461068601206 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier Science Bv | en_US |
dc.relation.ispartof | Journal Of Hepatology | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.title | Effectiveness and safety of direct-acting antiviral therapies in chronic hepatitis C infections patients with cirrhosis in Turkey | en_US |
dc.type | Conference Object | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1
Küçük Resim Yok
- İsim:
- 5784.pdf
- Boyut:
- 77.61 KB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Tam Metin / Full Text